Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation that plays a major role in immunosenescence and in development and progression of many diseases. But currently, there are no recognized standard biomarkers to assess SCI levels alone, and SCI is typically meas...
Enregistré dans:
Auteurs principaux: | Line Jee Hartmann Rasmussen, Jens Emil Vang Petersen, Jesper Eugen-Olsen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bdb1e3e2cd714f7ab8dcce84c7ff1e8b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19
par: Helena Enocsson, et autres
Publié: (2021) -
Anemia in the frail, elderly patient
par: Röhrig G
Publié: (2016) -
Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
par: Ulrich Jehn, et autres
Publié: (2021) -
Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit
par: Alexander C. Reisinger, et autres
Publié: (2021) -
Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.
par: Eva Haastrup, et autres
Publié: (2014)